Beta
Estrogen-containing contraceptives
medication Under reviewEstrogen-containing contraceptives are hormonal birth control methods that combine a synthetic estrogen (usually ethinyl estradiol) with a progestin. Common forms include combined oral contraceptive pills, transdermal patches, and vaginal rings, all designed primarily to prevent pregnancy. They work by delivering steady levels of hormones that override the natural menstrual cycle and provide predictable cycle control. These contraceptives prevent pregnancy through multiple mechanisms. Estrogen suppresses follicle-stimulating hormone (FSH) and helps prevent development of a dominant ovarian follicle, while progestins inhibit the luteinizing hormone (LH) surge to suppress ovulation, thicken cervical mucus to block sperm penetration, and induce changes in the endometrium that reduce implantation likelihood. Together, these actions make estrogen-containing contraceptives highly effective when used correctly, while also providing benefits such as more regular, lighter, and less painful menstrual periods. Beyond contraception, estrogen-containing methods are widely used for noncontraceptive indications. They are commonly prescribed to manage heavy menstrual bleeding, dysmenorrhea, acne, and menstrual-related symptoms, and they confer long-term reductions in the risk of endometrial, ovarian, and colorectal cancers. At the same time, they carry well-characterized risks, including small increases in venous thromboembolism, ischemic stroke, and certain hormone-related cancers, particularly in women with additional cardiovascular or cancer risk factors.
Research summary
Research on estrogen-containing contraceptives in healthy women is extensive and spans randomized trials, large cohort studies, and meta-analyses. The overall consensus is that combined hormonal methods are highly effective for pregnancy prevention, offer significant protection against endometrial and ovarian cancers, and modestly reduce colorectal cancer risk. They also consistently improve menstrual characteristics (lighter bleeding and more predictable cycles) and can reduce anemia risk by lowering menstrual blood loss. At the same time, long-term observational data show small but real increases in risk for venous thromboembolism, ischemic stroke, myocardial infarction, and breast and cervical cancers, with risk magnitude strongly influenced by estrogen dose, duration of use, age, smoking status, and other underlying cardiovascular risk factors. Modern low-dose formulations have lower absolute risk than older high-dose pills, but estrogen-containing contraceptives remain contraindicated or require caution in women with multiple cardiovascular risk factors or a history of thromboembolism. Overall, for most healthy, nonsmoking younger women, the benefits and convenience of these methods generally outweigh their risks when appropriately selected and monitored.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Estrogen-containing contraceptives to your stack to report effects
Combined oral contraceptives and risk of venous thromboembolism, ischemic stroke, and myocardial infarction: meta-analysis of observational studies
Roach REJ, Lijfering WM, Helmerhorst FM, Stijnen T, Algra A, Dekkers OM
Oral contraceptive use and cervical cancer risk: a pooled analysis of epidemiological studies
International Collaboration of Epidemiological Studies of Cervical Cancer
No reports yet
Be the first to report this effect and help the community.
Add Estrogen-containing contraceptives to your stack to report effects
Hormonal contraceptive use, systemic inflammation, and stress reactivity in healthy women
Gomez-Gonzalez A, van der Meij L, et al.
Combined oral contraceptives and risk of venous thromboembolism, ischemic stroke, and myocardial infarction: meta-analysis of observational studies
Roach REJ, Lijfering WM, Helmerhorst FM, Stijnen T, Algra A, Dekkers OM
No reports yet
Be the first to report this effect and help the community.
Add Estrogen-containing contraceptives to your stack to report effects
Hormonal contraceptive use, systemic inflammation, and stress reactivity in healthy women
Gomez-Gonzalez A, van der Meij L, et al.
No reports yet
Be the first to report this effect and help the community.
Add Estrogen-containing contraceptives to your stack to report effects
Hormonal contraceptive use, systemic inflammation, and stress reactivity in healthy women
Gomez-Gonzalez A, van der Meij L, et al.
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Estrogen-containing contraceptives to your stack to report effects
Oral contraceptive use and cervical cancer risk: a pooled analysis of epidemiological studies
International Collaboration of Epidemiological Studies of Cervical Cancer
No reports yet
Be the first to report this effect and help the community.
Add Estrogen-containing contraceptives to your stack to report effects
Oral contraceptive use and cervical cancer risk: a pooled analysis of epidemiological studies
International Collaboration of Epidemiological Studies of Cervical Cancer
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Tissue similar to uterine lining grows outside the uterus causing pain
Hormonal contraceptive use, systemic inflammation, and stress reactivity in healthy women
Gomez-Gonzalez A, van der Meij L, et al.
May Worsen
Coronary artery disease or other cardiac conditions
Oral contraceptive use and cervical cancer risk: a pooled analysis of epidemiological studies
International Collaboration of Epidemiological Studies of Cervical Cancer
Research (3 studies)
Hormonal contraceptive use, systemic inflammation, and stress reactivity in healthy women
Gomez-Gonzalez A, van der Meij L, et al.
Combined oral contraceptives and risk of venous thromboembolism, ischemic stroke, and myocardial infarction: meta-analysis of observational studies
Roach REJ, Lijfering WM, Helmerhorst FM, Stijnen T, Algra A, Dekkers OM
Oral contraceptive use and cervical cancer risk: a pooled analysis of epidemiological studies
International Collaboration of Epidemiological Studies of Cervical Cancer
Community updates
No updates yet for this supplement.
Be the first to share your experience!